NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Regeneron Pharmaceuticals, Inc. (“Regeneron” or the “Company”) (NASDAQ: REGN). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
Month: June 2024
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Bolt Biotherapeutics, Inc. (“Bolt” or the “Company”) (NASDAQ: BOLT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Oddity Tech Ltd. (“Oddity” or the “Company”) (NASDAQ: ODD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ecopetrol S.A. (“Ecopetrol” or the “Company”) (NYSE: EC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Verastem, Inc. (“Verastem” or the “Company”) (NASDAQ: VSTM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Hesai Group (“Hesai” or the “Company”) (NASDAQ: HSAI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Seritage Growth Properties (“Seritage” or the “Company”) (NYSE: SRG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of MacroGenics, Inc. (“MacroGenics” or the “Company”) (NASDAQ: MGNX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The…
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Target Hospitality Corp. (“Target Hospitality” or the “Company”) (NASDAQ: TH). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980….
NEW YORK, June 15, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of FutureFuel Corp. (“FutureFuel” or the “Company”) (NYSE: FF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation…